Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Hatice Nur Olgun MD"'
Autor:
Tekincan Çağrı Aktaş MD, PhD, Deniz Kızmazoğlu MD, PhD, Safiye Aktaş MD, PhD, Özde Elif Gökbayrak MSc, PhD, Efe Serinan MSc, PhD, Aylin Erol MSc, PhD, Zekiye Altun MD, PhD, Hongling Yuan MD, MSc, Hatice Nur Olgun MD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 22 (2023)
Background and Aim In neuroblastoma, anaplastic lymphoma kinase mutations have recently received attention as molecular targets for the treatment of neuroblastoma, as 6% to 10% of patients with neuroblastoma have anaplastic lymphoma kinase mutations.
Externí odkaz:
https://doaj.org/article/b74cbe39c43b4420a59edda52eb28096
